CE vs SER · rev $10.28B vs rev $56.0K
Celanese Corporation (CE) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
CE currently screens at market cap $5.92B. SER currently screens at market cap $29.7M.
Not investment advice. Open the CE and SER stock pages for the full models.
Not investment advice.